World Journal of Dentistry

Register      Login

VOLUME 10 , ISSUE 1 ( January-February, 2019 ) > List of Articles

ORIGINAL RESEARCH

Effect of Titanium Dioxide Nanoparticles on the Activity of Salivary Alkaline Phosphatase in Chronic Periodontitis Patients

Basima G Ali, Eaman A Al-Rubaee, Mays A Talib

Keywords : Chronic periodontitis, Enzyme activity, Saliva, Salivary alkaline phosphatase, titanium dioxide nanoparticles

Citation Information : Ali BG, Al-Rubaee EA, Talib MA. Effect of Titanium Dioxide Nanoparticles on the Activity of Salivary Alkaline Phosphatase in Chronic Periodontitis Patients. World J Dent 2019; 10 (1):1-6.

DOI: 10.5005/jp-journals-10015-1593

License: CC BY-NC 4.0

Published Online: 01-06-2019

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Background: Nanotechnology application has rapidly extended into all areas of life. It provides new methods to solve scientific and medical problems. Nanomaterials such as titanium dioxide nanoparticles (TiO2 NPs) has been used in biomedical applications. Biological influence of the nanoparticles appears to be as a result of the interactions between the nanoparticles and proteins. Salivary alkaline phosphatase (ALP) is an enzyme that is linked to the outer membrane of some cells and formed by many others. ALP activity increase in periodontal diseases especially in the active phase of the disease. Aim: The aim is to determine the effect of titanium dioxide nanoparticles on the enzymatic activity of alkaline phosphatase in the saliva of patients suffering from chronic periodontitis. Materials and methods: The influence of titanium dioxide nanoparticles on the enzymatic activity of salivary alkaline phosphatase was examined in 75 participants (44 with chronic periodontitis and 31 nonperiodontitis subjects). The age range of the participants was 35-50 years for both groups. The periodontal disease was determined based on the criteria of periodontal health through examination of plaque and gingival indices together with clinical attachment level and probing pocket depth. Unstimulated saliva was collected from all participants and analyzed. Results: The results showed that salivary alkaline phosphatase activity was higher in chronic periodontitis patients compare to the nonperiodontitis group and the enzyme activity was found to be not correlated with the periodontal parameters. The enzyme was activated by titanium dioxide nanoparticles. Conclusion: The effect of titanium dioxide nanoparticles may be attributed to the biological activity of this type of nanoparticles in addition to the conformational changes that can occur on the protein structure after interaction with NPs. Clinical significance: Recognition of the effect of some nanomaterials (such as titanium dioxide nanoparticles) on enzymes like alkaline phosphatase, may provide a potential therapeutic opportunity for some pathological conditions such as periodontal diseases.


PDF Share
  1. Adams DA, Barrington EP, Caton J, Genco RJ, Goodman SF, Hildebrand CN, et al. Parameters of Care Supplement. J Periodontol. 2000;71(5):847-883.
  2. Lindhe J, Lang NP, editors. Clinical Periodontology and Implant Dentistry. 6th ed. Vol. 1, Wiley Blackwell. Wiley Blackwell; 2015. p 556.
  3. Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Curr Opin Orthop. 2007;18:444-448.
  4. Millaìn JL. Mammalian alkaline phosphatases : from biology to applications in medicine and biotechnology. John Wiley & Sons; 2006. p 337.
  5. Shibata Y, Yamashita Y, Miyazaki H, Ueno S, Takehara T. Effective method for discriminating between oral bacterial and human alkaline phosphatase activity. Oral Microbiol Immunol. 1994;9(1):35-39.
  6. Chapple IL, Garner I, Saxby MS, Moscrop H, Matthews JB. Prediction and diagnosis of attachment loss by enhanced chemiluminescent assay of crevicular fluid alkaline phosphatase levels. J Clin Periodontol. 1999;26(3):190-198.
  7. Gibert P, Tramini P, Sieso V, Piva MT. Alkaline phosphatase isozyme activity in serum from patients with chronic periodontitis. J Periodontal Res. 2003;38(4):362-365.
  8. Kinney JS, Ramseier CA, Giannobile WV. Oral Fluid-Based Biomarkers of Alveolar Bone Loss in Periodontitis. Ann N Y Acad Sci. 2007;1098(1):230-251.
  9. Logothetidis S, editor. Nanostructured Materials and Their Applications. 1st ed. Berlin: Springer; 2012. 220 p.
  10. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology Applications in Cancer. Annu Rev Biomed Eng. 2007;9(1):257-288.
  11. De Jong WH, Borm PJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3(2):133-149.
  12. Bystrzejewska-Piotrowska G, Golimowski J, Urban PL. Nanoparticles: Their potential toxicity, waste and environmental management. Waste Manag. 2009 Sep;29(9):2587-2595.
  13. Zupancic S, Kocbek P, Baumgartner S, Kristl J. Contribution of Nanotechnology to Improved Treatment of Periodontal Disease. Curr Pharm Des. 2015;21(22):3257-3271.
  14. Thomas J. Webster, editor. Safety of Nanoparticles: From Manufacturing to Medical Applications. 1st ed. New York: Springer ; 2008. p 239.
  15. Fei Yin Z, Wu L, Gui Yang H, Hua Su Y. Recent progress in biomedical applications of titanium dioxide. Phys Chem Chem Phys. 2013;15(14):4844-4858.
  16. Löe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967 Nov;38(6):610-616.
  17. SILNESS J, LOE H. Periodontal disease in pregnancy. ii. correlation between oral hygiene and periodontal condtion. Acta Odontol Scand. 1964;22:121-135.
  18. AL-rubaee EAS, Abd ST, Kadim NM. The Effect of Titanium Dioxide Nanoparticles on Salivary Alkaline Phosphatase Activity. Eur J Mol Biotechnol. 2015;10(4):188-196.
  19. Yoshie H, Tai H, Kobayashi T, Oda-Gou E, Nomura Y, Numabe Y, et al. Salivary Enzyme Levels After Scaling and Interleukin-1 Genotypes in Japanese Patients With Chronic Periodontitis. J Periodontol. 2007;78(3):498-503.
  20. Trivedi D, Trivedi C. salivary proteome in periodontal diagnosis. Int J Pharma Bio Sci. 2012;3(2):241-245.
  21. Yan F, Cao C, Li X. Alkaline phosphatase levels in gingival crevicular fluid of periodontitis before and after periodontal treatment. Chinese J Stomatol. 1995;30(4):204-206, 255-256.
  22. Kumar R, Sharma G. Salivary Alkaline Phosphatase level as Diagnostic marker for periodontal disease. J Int Oral Heal. 2011;3(5):82-85.
  23. Sophia K, Suresh S, Sudhakar U, Jayakumar P, Mathew D. Comparative Analysis of Salivary Alkaline Phosphatase in Post menopausal Women with and without Periodontitis. J Clin Diagn Res. 2017;11(1):122-124.
  24. Ozmeric N. Advances in periodontal disease markers. Clin Chim Acta. 2004 May;343(1–2):1-16.
  25. Numabe Y, Hisano A, Kamoi K, Yoshie H IK, H. K. Analysis of saliva for periodontal diagnosis and monitoring. J Periodontol. 2004;(40):115-119.
  26. Kaufman E LI. Analysis of saliva for periodontal diagnosis. J Clin Periodontol. 2000;27:453-465.
  27. Abdul-Hadi MJ, Alsafi KAS. Evaluation of salivary enzymes activities among patients with chronic periodontitis. J Bagh Coll Dent. 2010;22(1):65-67.
  28. Bezerra Júnior AA, Pallos D, Cortelli JR, Saraceni CHC, Queiroz CS. Evaluation of organic and inorganic compounds in the saliva of patients with chronic periodontal disease. Rev Odonto Ciênc. 2010;25(3):234-238.
  29. Saliem SS, Mousa HA. Assessment of Alkaline Phosphatase, Salivary Flow Rate and Salivary Potential of Hydrogen in Relation to Severity of Chronic Periodontitis. J Bagh Coll Dent. 2016;28(3):125-131.
  30. Todorovic T, Dozic I, Vicente-Barrero M, Ljuskovic B, Pejovic J, Marjanovic M, et al. Salivary enzymes and periodontal disease. Med Oral Patol Oral Cir Bucal. 2006;11:115-119.
  31. A.S. Al-Rubaee E, Salman ZA, Abd ST, Aziz RA. Kinetic study of the effect of Titanium Dioxide Nanoparticles on salivary peroxidase activity. Int J Biol Res. 2016;1(1):56-59.
  32. Ibrahim LM, Ghudhaib KK, Al-Rubaee EA, Salman ZA. Estimation of ZnO Nanoparticles Effect on Salivary ALP Activity in Chronic Periodontitis Patients : in vitro study. Int J Adv Res Biol Sci. 2016;3(4):152-159.
  33. Pandurangan M, Kim DH. ZnO nanoparticles augment ALT, AST, ALP and LDH expressions in C2C12 cells. Saudi J Biol Sci. 2015;22(6):679-684.
  34. Ghudhaib KK, Ibrahim L, Al-Rubaee EA, Salman ZA. Assessment of ZnO Nanoparticles Effect on AST Activity in Saliva of Patients with Chronic periodontitis: in vitro study. Int J Adv Res Biol Sci. 2016;3(6):179-186.
  35. Talalabd S, Lafta Abdulla W, Ali Salman R, Ali Salman Z. Comparison the Activity of ALT Enzyme in Saliva of Periodontitis Patients with Control and Determine the Effect of ZnONPs on its Activity. Int J Sci Res. 2017;6(1):2197-2200.
  36. Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology. 2013 Jul 19;11(1):26.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.